Physician profile
Christopher Wang
NPI 1043914575
$1,416.90
in general payments reported to CMS, 2019-2025
7 companies · $773 in 2025
The $773 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $415 · 2024: $229 · 2025: $773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002 · Education: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.90 |
| Education | $415.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $550.36 | 2023-2024 | Core, Delta, Duramatrix |
| Incyte Corporation | $241.63 | 2025 | Opzelura, Opzelura |
| Medtronic, INC. | $168.02 | 2025 | Mazor X System, Strata, O-Arm |
| Regeneron Healthcare Solutions, INC. | $124.99 | 2025 | Libtayo |
| Amgen INC. | $123.14 | 2025 | Otezla |
| Baxter Healthcare | $115.38 | 2025 | Floseal |
| Depuy Synthes Sales INC. | $93.38 | 2024 | Cranioplastic, Matrixneuro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.